Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges.
Saved in:
| Title: | Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges. |
|---|---|
| Authors: | Rubsamen RM; School of Medicine, Case Western Reserve University, Cleveland, OH, United States.; University Hospitals Cleveland Medical Center, Cleveland, OH, United States., Sloan AE; Piedmont Healthcare, Atlanta, GA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Feb 23; Vol. 15, pp. 1363282. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1363282 |
